215 related articles for article (PubMed ID: 28129312)
1. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I
J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
3. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
[TBL] [Abstract][Full Text] [Related]
4. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
[TBL] [Abstract][Full Text] [Related]
5. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
Praharaj SK; Munoli RN; Sharma PS
J Clin Psychopharmacol; 2014 Jun; 34(3):392. PubMed ID: 24717248
[No Abstract] [Full Text] [Related]
6. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N
J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092
[TBL] [Abstract][Full Text] [Related]
7. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
Blissit KT; Tillery E; Latham C; Pacheco-Perez J
Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
[TBL] [Abstract][Full Text] [Related]
8. Glycopyrrolate for clozapine-induced sialorrhea.
Duggal HS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1546-7. PubMed ID: 17614181
[No Abstract] [Full Text] [Related]
9. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
10. Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.
Kreinin A; Miodownik C; Mirkin V; Gaiduk Y; Yankovsky Y; Bersudsky Y; Lerner PP; Bergman J; Lerner V
J Clin Psychopharmacol; 2016 Jun; 36(3):200-5. PubMed ID: 27028980
[TBL] [Abstract][Full Text] [Related]
11. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
Mubaslat O; Lambert T
Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.
Bai YM; Lin CC; Chen JY; Liu WC
J Clin Psychopharmacol; 2001 Dec; 21(6):608-11. PubMed ID: 11763010
[TBL] [Abstract][Full Text] [Related]
13. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
[TBL] [Abstract][Full Text] [Related]
14. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
Segev A; Evans A; Hodsoll J; Whiskey E; Sheriff RS; Shergill S; MacCabe JH
Int Clin Psychopharmacol; 2019 Mar; 34(2):101-107. PubMed ID: 30614850
[TBL] [Abstract][Full Text] [Related]
15. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
Garnock-Jones KP
Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H
Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710
[TBL] [Abstract][Full Text] [Related]
17. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea.
Leung JG; Puri NV; Jacobson MJ
Ann Pharmacother; 2011 Sep; 45(9):e45. PubMed ID: 21852588
[TBL] [Abstract][Full Text] [Related]
18. Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl.
Praharaj SK; Sarkhel S; Khanande RV; Sinha VK
Psychopharmacol Bull; 2010; 43(4):73-5. PubMed ID: 21240153
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride improved debilitating clozapine-induced sialorrhea.
Praharaj SK; Ray P; Gandotra S
Am J Ther; 2011 May; 18(3):e84-5. PubMed ID: 20068443
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Kreinin A; Novitski D; Weizman A
Int Clin Psychopharmacol; 2006 Mar; 21(2):99-103. PubMed ID: 16421461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
